Parang K - Search Results

1

Design, Synthesis, and Evaluation of Dasatinib-Amino Acid and Dasatinib-Fatty Acid Conjugates as Protein Tyrosine Kinase Inhibitors.

Tiwari RK, Brown A, Sadeghiani N, Shirazi AN, Bolton J, Tse A, Verkhivker G, Parang K, Sun G. Tiwari RK, et al. Among authors: parang k. ChemMedChem. 2017 Jan 5;12(1):86-99. doi: 10.1002/cmdc.201600387. Epub 2016 Dec 5. ChemMedChem. 2017. PMID: 27875633 Free PMC article.

2

Determination of the substrate-docking site of protein tyrosine kinase C-terminal Src kinase.

Lee S, Lin X, Nam NH, Parang K, Sun G. Lee S, et al. Among authors: parang k. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14707-12. doi: 10.1073/pnas.2534493100. Epub 2003 Dec 1. Proc Natl Acad Sci U S A. 2003. PMID: 14657361 Free PMC article.

3

Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.

Nam NH, Pitts RL, Sun G, Sardari S, Tiemo A, Xie M, Yan B, Parang K. Nam NH, et al. Among authors: parang k. Bioorg Med Chem. 2004 Feb 15;12(4):779-87. doi: 10.1016/j.bmc.2003.10.060. Bioorg Med Chem. 2004. PMID: 14759738

4

Conformationally constrained peptide analogues of pTyr-Glu-Glu-Ile as inhibitors of the Src SH2 domain binding.

Nam NH, Ye G, Sun G, Parang K. Nam NH, et al. Among authors: parang k. J Med Chem. 2004 Jun 3;47(12):3131-41. doi: 10.1021/jm040008+. J Med Chem. 2004. PMID: 15163193

5

ATP-phosphopeptide conjugates as inhibitors of Src tyrosine kinases.

Nam NH, Lee S, Ye G, Sun G, Parang K. Nam NH, et al. Among authors: parang k. Bioorg Med Chem. 2004 Nov 15;12(22):5753-66. doi: 10.1016/j.bmc.2004.08.043. Bioorg Med Chem. 2004. PMID: 15498652

6

Design strategies for protein kinase inhibitors.

Parang K, Sun G. Parang K, et al. Curr Opin Drug Discov Devel. 2004 Sep;7(5):617-29. Curr Opin Drug Discov Devel. 2004. PMID: 15503864 Review.

7

Probing the communication between the regulatory and catalytic domains of a protein tyrosine kinase, Csk.

Lin X, Ayrapetov MK, Lee S, Parang K, Sun G. Lin X, et al. Among authors: parang k. Biochemistry. 2005 Feb 8;44(5):1561-7. doi: 10.1021/bi048142j. Biochemistry. 2005. PMID: 15683240

8

Functional diversity of Csk, Chk, and Src SH2 domains due to a single residue variation.

Ayrapetov MK, Nam NH, Ye G, Kumar A, Parang K, Sun G. Ayrapetov MK, et al. Among authors: parang k. J Biol Chem. 2005 Jul 8;280(27):25780-7. doi: 10.1074/jbc.M504022200. Epub 2005 May 12. J Biol Chem. 2005. PMID: 15890649 Free article.

9

Solid-phase binding assays of peptides using EGFP-Src SH2 domain fusion protein and biotinylated Src SH2 domain.

Ye G, Ayrapetov M, Nam NH, Sun G, Parang K. Ye G, et al. Among authors: parang k. Bioorg Med Chem Lett. 2005 Nov 15;15(22):4994-7. doi: 10.1016/j.bmcl.2005.08.005. Bioorg Med Chem Lett. 2005. PMID: 16169725

10

Docking-based substrate recognition by the catalytic domain of a protein tyrosine kinase, C-terminal Src kinase (Csk).

Lee S, Ayrapetov MK, Kemble DJ, Parang K, Sun G. Lee S, et al. Among authors: parang k. J Biol Chem. 2006 Mar 24;281(12):8183-9. doi: 10.1074/jbc.M508120200. Epub 2006 Jan 26. J Biol Chem. 2006. PMID: 16439366 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

209 results

Search Page

Filters